Gregory Minevich

As director of science at CytoReason, Gregory Minevich leads multidisciplinary efforts to harness AI, omics data, and scientific literature for drug development. Gregory’s core expertise lies in building computational models that integrate diverse molecular, clinical, and text data. He has a PhD in Pathobiology and Molecular Medicine from Columbia, a master's degree in Information Systems from LSE, and a master's degree in Biotechnology from Columbia.